Stocks and Investing
by (remove) : Pete Stavropoulos
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Pete Stavropoulos
RSSJSONXMLCSV
Thu, October 3, 2024
Tue, October 1, 2024
Mon, September 23, 2024
Mon, September 16, 2024
Mon, September 9, 2024
Fri, September 6, 2024
Tue, August 6, 2024
Mon, July 29, 2024
Thu, June 20, 2024
Wed, June 5, 2024
Thu, May 9, 2024
Wed, April 24, 2024
Wed, April 3, 2024
Mon, January 8, 2024
Fri, September 22, 2023
Tue, August 22, 2023
Tue, August 8, 2023
Tue, August 1, 2023
Mon, July 17, 2023
Fri, July 14, 2023
Thu, May 18, 2023
Tue, March 14, 2023
Wed, November 2, 2022
Tue, August 16, 2022

Pete Stavropoulos Reiterated (VERA) at Buy and Held Target at $107 on, Oct 3rd, 2024


Published on 2024-10-28 14:37:16 - WOPRAI, Pete Stavropoulos
  Print publication without navigation


Pete Stavropoulos of Cantor Fitzgerald, Reiterated "Vera Therapeutics, Inc." (VERA) at Buy and Held Target at $107 on, Oct 3rd, 2024.

Pete has made no other calls on VERA in the last 4 months.



There is 1 other peer that has a rating on VERA. Out of the 1 peers that are also analyzing VERA, 0 agree with Pete's Rating of Hold.



This is the rating of the analyst that currently disagrees with Pete


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $72 on, Tuesday, September 3rd, 2024
Contributing Sources